The Summit

23rd - 25th July 2012

NG Pharma Summit 2012

Summit Venue
Barton Creek Resort & Spa, Austin, Texas

The Next Generation Pharmaceutical Summit has grown to become the standard for senior level pharmaceutical executives looking to share ideas with peers, build partnerships with industry thought leaders, and hear from key experts on how to address some of their most pressing challenges in discovery and development, clinical research and beyond.

  • Previous Summits

View All Media Partners

Technology Networks

Technology Networks were established over 10 years ago with the aim of providing informative websites for life science professionals. From our UK headquarters we provide an outstanding web-based information solution for the Life Science and Drug Discovery community and have recently expanded our portfolio to include over 30 communities.

Find out more

Past and Present VIP Attendees

Diane Jorkasky

Diane Jorkasky

VP of Global Clinical Research Operations
Pfizer Inc.

Francesco M. Marincola

Francesco M. Marincola

Chief Infectious Disease
NIH

Jean-Pierre Bizzari

Jean-Pierre Bizzari

VP of Clinical Development, Oncology
sanofi-aventis

Christian Jacques

Christian Jacques

VP Clinical Development
Celgene

Coreen Oei

Coreen Oei

VP Clinical Sciences & Study Operations
GSK

Kirk Shepard

Kirk Shepard

SVP Medical & Scientific Affairs
Takeda Pharmaceuticals

John Smith

John Smith

VP Clinical Research
Boehringer Ingelheim Pharmaceuticals, Inc.

Francis Cuss

Francis Cuss

SVP Discovery and Exploratory Clinical Research
Bristol Myers-Squibb

Amrit Ray

Amrit Ray

VP Global Pharmacovigilance & Epidemiology – Medical Safety
Bristol-Myers Squibb

Oscar Laskin

Oscar Laskin

VP Early Drug Development
Celgene

Anne Phillips

Anne Phillips

VP of Discovery Medicine
GSK

Stephen Eck

Stephen Eck

VP Translational Medicine & Pharmacogenomics
Eli Lilly

Haren Rupani

Haren Rupani

Global Head Oncology Clinical Imaging
Novartis

Robert Spiegel

Robert Spiegel

Chief Medical Officer and SVP
Schering-Plough Corporation

Ismail Kola

Ismail Kola

SVP Discovery Research and Chief Scientific Officer
Schering-Plough Corporation

Thorir D. Bjornsson

Thorir D. Bjornsson

VP Early Development and Clinical Pharmacology
Wyeth

Giora Z. Feuerstein

Giora Z. Feuerstein

Assistant VP Translational Medicine
Wyeth

Kenneth Kaitin

Kenneth Kaitin

Director
Tufts Center for the Study of Drug Development

Dr. Thomas Haverty

Dr. Thomas Haverty

Group Vice President of Global Clinical Research
Schering-Plough Corporation

Dr. David Spencer

Dr. David Spencer

COO and SVP of Research and Development
Biolex